GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transcenta Holding Ltd (HKSE:06628) » Definitions » Beneish M-Score

Transcenta Holding (HKSE:06628) Beneish M-Score : -2.47 (As of Jun. 04, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Transcenta Holding Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.47 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Transcenta Holding's Beneish M-Score or its related term are showing as below:

HKSE:06628' s Beneish M-Score Range Over the Past 10 Years
Min: -2.62   Med: -2.47   Max: 0.94
Current: -2.47

During the past 5 years, the highest Beneish M-Score of Transcenta Holding was 0.94. The lowest was -2.62. And the median was -2.47.


Transcenta Holding Beneish M-Score Historical Data

The historical data trend for Transcenta Holding's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcenta Holding Beneish M-Score Chart

Transcenta Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - 0.94 -2.62 -2.47

Transcenta Holding Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only 0.94 - -2.62 - -2.47

Competitive Comparison of Transcenta Holding's Beneish M-Score

For the Biotechnology subindustry, Transcenta Holding's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transcenta Holding's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transcenta Holding's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Transcenta Holding's Beneish M-Score falls into.



Transcenta Holding Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Transcenta Holding for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 2.1507+0.528 * 0.73+0.404 * 1.1565+0.892 * 0.5176+0.115 * 0.9894
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.9232+4.679 * -0.06173-0.327 * 1.29
=-2.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$57.22 Mil.
Revenue was HK$58.90 Mil.
Gross Profit was HK$15.75 Mil.
Total Current Assets was HK$748.19 Mil.
Total Assets was HK$1,852.10 Mil.
Property, Plant and Equipment(Net PPE) was HK$480.67 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$58.84 Mil.
Selling, General, & Admin. Expense(SGA) was HK$54.55 Mil.
Total Current Liabilities was HK$606.27 Mil.
Long-Term Debt & Capital Lease Obligation was HK$30.59 Mil.
Net Income was HK$-505.95 Mil.
Gross Profit was HK$0.00 Mil.
Cash Flow from Operations was HK$-391.62 Mil.
Total Receivables was HK$51.40 Mil.
Revenue was HK$113.78 Mil.
Gross Profit was HK$22.21 Mil.
Total Current Assets was HK$1,179.78 Mil.
Total Assets was HK$2,383.68 Mil.
Property, Plant and Equipment(Net PPE) was HK$510.30 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$61.72 Mil.
Selling, General, & Admin. Expense(SGA) was HK$54.79 Mil.
Total Current Liabilities was HK$614.61 Mil.
Long-Term Debt & Capital Lease Obligation was HK$20.79 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(57.222 / 58.899) / (51.4 / 113.784)
=0.971528 / 0.451733
=2.1507

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(22.21 / 113.784) / (15.748 / 58.899)
=0.195194 / 0.267373
=0.73

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (748.192 + 480.669) / 1852.095) / (1 - (1179.781 + 510.302) / 2383.678)
=0.336502 / 0.290977
=1.1565

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=58.899 / 113.784
=0.5176

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(61.717 / (61.717 + 510.302)) / (58.835 / (58.835 + 480.669))
=0.107893 / 0.109054
=0.9894

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(54.545 / 58.899) / (54.789 / 113.784)
=0.926077 / 0.481518
=1.9232

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((30.589 + 606.273) / 1852.095) / ((20.79 + 614.606) / 2383.678)
=0.34386 / 0.266561
=1.29

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-505.949 - 0 - -391.62) / 1852.095
=-0.06173

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Transcenta Holding has a M-score of -2.47 suggests that the company is unlikely to be a manipulator.


Transcenta Holding Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Transcenta Holding's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Transcenta Holding (HKSE:06628) Business Description

Traded in Other Exchanges
N/A
Address
B6-501, 218 Xinghu Street, Biobay, Suzhou, CHN, 215123
Transcenta Holding Ltd is a clinical stage biopharmaceutical company with fully integrated capacities in discovery, research, development and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the "PRC") and the USA.
Executives
Qian Xueming 2101 Beneficial owner
Shi Xiaohong 2501 Other
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Lav Gp Iii, L.p. 2201 Interest of corporation controlled by you
Lav Biosciences Fund Iii, L.p. 2101 Beneficial owner
Shi Yi 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited
Tls Beta Pte. Ltd.
Hsbc Trust Company (delaware), N.a. 2301 Trustee
Success Link International L.p. 2101 Beneficial owner
Temasek Holdings (private) Limited
Lav Vitality Limited 2101 Beneficial owner
Zhong Guo Guo You Qi Ye Jie Gou Tiao Zheng Ji Jin Gu Fen You Xian Gong Si 2501 Other

Transcenta Holding (HKSE:06628) Headlines

No Headlines